 Released: Jul 9, 2008
Expires: Jul 8, 2009
Type: Video
Advances in immunosuppressive drug therapy have contributed greatly to the success of solid organ transplantation. Unfortunately, improvements in short-term outcomes as a result of advances in immunosuppressive protocols have yet translated into greater long-term graft survival. Graft survival half-life, a measure of long-term outcome in kidney transplantation, has changed only...
|
- CME Credits/Hours: 1.50
- CNE Credits/Hours: 1.50
- CPE Credits/Hours: 1.50
- Cost: Free
-
System Requirements:
|
Released: Jul 1, 2008
Expires: Jun 30, 2009
Type: PDF
The International Journal of Advances in Rheumatology, a CME/CPE/CNE-accredited educational program, systematically identifies, evaluates, and places into clinical context the most important recent studies into the science and medicine of rheumatoid diseases. It provides rapid access for busy specialists to a critical and clinically relevant review of the developments that...
|
- CME Credits/Hours: 2.00
- CPE Credits/Hours: 2.00
- CNE Credits/Hours: 2.00
- Cost: Free
-
System Requirements:
|
Released: Jun 11, 2008
Expires: Jun 10, 2009
Type: PDF
Rheumatoid arthritis (RA) currently afflicts 1.3 million American adults. A progressive disease of the joints with a recognized autoimmune component, RA causes eventual loss of joint structure and function. The disease is also associated with serious extraarticular and comorbid disease, evidenced by studies identifying a 10-15 year shorter lifespan for patients with RA. RA...
|
- CME Credits/Hours: 1.00
- CPE Credits/Hours: 1.00
- CNE Credits/Hours: 1.00
- Cost: Free
-
System Requirements:
|
Released: May 22, 2008
Expires: May 25, 2009
Type: PDF
Cytomegalovirus disease (CMV) adversely affects short and long term outcomes following transplantation of allogeneic kidneys, hearts, lungs and livers. Disease prevention strategies, including prophylactic treatment with gancyclovir and related antiviral agents, are routinely implemented in seronegative recipients of organs from seropositive donors (D+/R-). CMV...
|
- CME Credits/Hours: 1.00
- CPE Credits/Hours: 1.00
- CNE Credits/Hours: 1.00
- Cost: Free
-
System Requirements:
|
Released: Feb 19, 2008
Expires: Feb 19, 2009
Type: Video
Biologic agents that block TNF have proven highly effective in improving the signs and symptoms of rheumatoid arthritis (RA), preventing the progression of joint damage, and improving functional status and quality of life. The introduction of TNF inhibitors has helped elevate the goals of treating RA, such that low disease activity or even remission are commonly considered...
|
- CME Credits/Hours: 0.50
- CPE Credits/Hours: 0.50
- CNE Credits/Hours: 0.50
- Cost: Free
-
System Requirements:
|
Released: Feb 19, 2008
Expires: Feb 19, 2009
Type: Video
Biologic agents that block TNF have proven highly effective in improving the signs and symptoms of rheumatoid arthritis (RA), preventing the progression of joint damage, and improving functional status and quality of life. The introduction of TNF inhibitors has helped elevate the goals of treating RA, such that low disease activity or even remission are commonly considered...
|
- CME Credits/Hours: 0.50
- CPE Credits/Hours: 0.50
- CNE Credits/Hours: 0.50
- Cost: Free
-
System Requirements:
|
Released: Feb 19, 2008
Expires: Feb 19, 2009
Type: Video
Biologic agents that block TNF have proven highly effective in improving the signs and symptoms of rheumatoid arthritis (RA), preventing the progression of joint damage, and improving functional status and quality of life. The introduction of TNF inhibitors has helped elevate the goals of treating RA, such that low disease activity or even remission are commonly considered...
|
- CME Credits/Hours: 0.50
- CPE Credits/Hours: 0.50
- CNE Credits/Hours: 0.50
- Cost: Free
-
System Requirements:
|
Released: Feb 19, 2008
Expires: Feb 19, 2009
Type: Video
Biologic agents that block TNF have proven highly effective in improving the signs and symptoms of rheumatoid arthritis (RA), preventing the progression of joint damage, and improving functional status and quality of life. The introduction of TNF inhibitors has helped elevate the goals of treating RA, such that low disease activity or even remission are commonly considered...
|
- CME Credits/Hours: 0.50
- CPE Credits/Hours: 0.50
- CNE Credits/Hours: 0.50
- Cost: Free
-
System Requirements:
|
Released: Feb 15, 2008
Expires: Feb 14, 2009
Type: PDF
Rheumatology Highlights, a CME-accredited educational program, presents a carefully constructed report from a major international conference and is developed to equip readers with practical knowledge of the area under discussion. This newsletter is commissioned to support particular educational themes identified by the Editor-in-Chief, Editorial team and readers. This issue...
|
- CME Credits/Hours: 1.00
- CPE Credits/Hours: 1.00
- CNE Credits/Hours: 1.00
- Cost: Free
-
System Requirements:
|
Released: Nov 30, 2007
Expires: Nov 30, 2008
Type: PDF
Acute coronary syndrome (ACS) is a broad term that has evolved to represent a spectrum of diseases from unstable angina (UA) to myocardial infarction (MI) with or without ST-segment elevation (STEMI or NSTEMI, respectively). While these conditions have very different presentations and are associated with differing levels of risk, they appear to share a common pathophysiologic...
|
- CME Credits/Hours: 1.00
- CNE Credits/Hours: 1.00
- CPE Credits/Hours: 1.00
- Cost: Free
-
System Requirements:
|
Released: Nov 19, 2007
Expires: Nov 19, 2008
Type: PDF
The trend to minimize the use of calcineurin inhibitors (CNIs) and corticosteroids (CSs) has contributed to an increase in the use of antibody induction therapy in kidney and liver transplantation. Significant comorbid conditions associated with historical maintenance immunosuppressive regimens consisting of CNIs and CSs have resulted in a paradigm shift in clinical practice....
|
- CME Credits/Hours: 1.00
- CPE Credits/Hours: 1.20
- CNE Credits/Hours: 1.00
- Cost: Free
-
System Requirements:
|
Released: Sep 19, 2007
Expires: Nov 9, 2008
Type: PDF
Rheumatoid arthritis (RA) afflicts 2.1 million Americans. A progressive disease of the joints with a recognized autoimmune component, RA is often associated with debilitating pain and stiffness, and eventual loss of joint function in many patients. In addition, RA may be associated with serious extraarticular disease, and significant comorbidities, best revealed by studies...
|
- CME Credits/Hours: 1.00
- CPE Credits/Hours: 1.20
- CNE Credits/Hours: 1.00
- Cost: Free
-
System Requirements:
|
Released: Oct 16, 2007
Expires: Oct 16, 2008
Type: Video
The majority of hospitalized patients are at risk for venous thromboembolism (VTE), which is comprised of deep vein thrombosis (DVT) and pulmonary embolism (PE). Medically ill patients—for example, those with congestive heart failure, respiratory illness, or infectious or inflammatory disease—are at an increased risk of developing VTE. VTE is the most common...
|
- CME Credits/Hours: 1.00
- CPE Credits/Hours: 1.00
- CNE Credits/Hours: 1.00
- Cost: Free
-
System Requirements:
|
Released: Oct 16, 2007
Expires: Oct 16, 2008
Type: Video
The majority of hospitalized patients are at risk for venous thromboembolism (VTE), which is comprised of deep vein thrombosis (DVT) and pulmonary embolism (PE). Medically ill patients—for example, those with congestive heart failure, respiratory illness, or infectious or inflammatory disease—are at an increased risk of developing VTE. VTE is the most common...
|
- CME Credits/Hours: 1.75
- CPE Credits/Hours: 1.75
- CNE Credits/Hours: 1.75
- Cost: Free
-
System Requirements:
|
Released: Aug 23, 2007
Expires: Aug 23, 2008
Type: PDF
Rheumatoid arthritis (RA) afflicts 2.1 million Americans (www.niams.nih.gov). A progressive disease of the joints with a recognized autoimmune component, RA causes debilitating pain and stiffness, and eventual loss of joint function. By 10 years following diagnosis, greater than 50% of patients are no longer able to work, underscoring the...
|
- CME Credits/Hours: 2.00
- CPE Credits/Hours: 2.00
- CNE Credits/Hours: 2.00
- Cost: Free
-
System Requirements:
|
Released: Jul 26, 2007
Expires: Jul 26, 2008
Type: Video
Significant toxicity associated with lifelong maintenance on immunosuppressive therapy continues to fuel the investigation of tolerance-inducing strategies in solid organ transplantation. One approach to achieve tolerance is focused on regulatory T cells. Regulatory T cells (T reg) are a population of antigen-specific T lymphocytes that have been shown...
|
- CME Credits/Hours: 1.50
- CPE Credits/Hours: 1.50
- CNE Credits/Hours: 1.50
- Cost: Free
-
System Requirements:
|
|
